Last reviewed · How we verify
InductOs
At a glance
| Generic name | InductOs |
|---|---|
| Sponsor | Wyeth is now a wholly owned subsidiary of Pfizer |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- CONDUIT vs. PEEK Cages (NA)
- Effect of Mandibular Drilling Speed on Implant Stability and Osteogenic Potential: A Randomized Clinical Trial (NA)
- Cost Effectiveness in Alveolar Bone Grafting in Patients With Cleft Lip and Palate (PHASE4)
- Transforaminal Lumbar Interbody Fusion (TLIF) (NA)
- LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF) (PHASE1, PHASE2)
- Release Kinetics of rhBMP-2 Using E-PRF as an Autologous Carrier: An In Vitro Analysis
- BMP Effect on Implant Stability and Marginal Bone Level After Immediate Placement (NA)
- BMAC & Allograft vs BMP-2 (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- InductOs CI brief — competitive landscape report
- InductOs updates RSS · CI watch RSS
- Wyeth is now a wholly owned subsidiary of Pfizer portfolio CI